Introduction
Bone morphogenetic proteins (BMPs) are secreted signaling molecules belonging to the transforming growth factor-b (TGF-b) superfamily. More than 30 members in the BMP family are termed as either BMPs, osteogenic proteins (OPs), growth/differentiation factors (GDFs), or cartilage-derived morphogenetic proteins (CDMPs). [1] [2] [3] Members of the BMP family are divided into separate subgroups based on similarity of primary ammo acid sequences. One group consists of BMP-2, BMP-4, Drosophila decapentapiegic (Dpp), Xenopus vegetal-1 (Vg-1), and Sea urchin Univin. A second group includes BMP-5, BMP-6, BMP-7 (OP-1), and BMP-8 (OP-2), which are closely related to one another with 89% amino acid sequence identities in their corresponding regions. A third group is GDF-5, GDF-6 (BMP-13), and GDF-7 (BMP-12). A fourth group contains BMP-9 and BMP-10. A fifth group has GDF-10 (BMP-3b) and BMP-3. The BMP family still contains other members in addition to those given in the above groups. 1 In this study, the osteogenic potentials of cDNAs of human BMP-2, BMP-4, BMP-6, BMP-7, and BMP-9 in recombinant adenoviruses were examined.
BMPs govern the three key steps in the bone induction cascade that includes chemotaxis and mitosis of mesenchymal cells, differentiation of the mesenchymal cells initially into cartilage, and replacement of the cartilage by bone. In addition, BMPs also regulate hematopoiesis, stimulate extracellular matrix synthesis, and influence cell survival maintenance and cell death (apoptosis). 4 The ability of different BMPs to stimulate bone formation has been tested in vitro and in vivo. Some BMPs can induce bone formation in mice, rats, rabbits, sheep, dogs, monkeys, and baboons. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Purified BMP-2, BMP-4, and BMP-7 have been used in human clinical cases to repair resistant nonunions and segmental defects of long bones. [19] [20] [21] [22] [23] In a previous study, the ability of recombinant human BMP-2, BMP-3, BMP-4, BMP-5, BMP-6, and BMP-7 to stimulate DNA synthesis was compared in cultures of periosteal cells and epiphyseal and sternal chondrocytes of embryonic chick. BMP-2 and BMP-4 exhibited the highest specific activity in these three cell types. BMP-5 and BMP-6 activity was moderately reduced in periosteal cells and highly reduced in epiphyseal and sternal chondrocytes. The specific activity of BMP-7 was the lowest in the three tested cell cultures. 24 The effects of BMP-2, BMP-4, and BMP-6 were also compared in fetal rat secondary calvarial cell culture system, rat osteoprogenitor cells, and bone marrow stromal cells. [25] [26] [27] The relative activity of different BMPs varied among the cell types exposed to these proteins. Among gene delivery vehicles, viral vectors are the most efficient tools in the field of gene therapy. The BMP viral vectors include recombinant adenovirus, retrovirus and baculovirus. 13, [28] [29] [30] [31] [32] [33] Gysin et al 34 demonstrated that recombinant BMP-4 retrovirus-transduced stromal cells embedded in a gelatin matrix could heal critical size defects in calvariae of syngeneic rats. Gelatin matrices without cells and with untransduced stromal cells were the two control groups. The defect area was completely filled with new bone in experimental rats after 4 weeks, while limited bone formation occurred in both control groups. Recombinant BMP-2, BMP-4, and BMP-7 baculoviruses were tested in a mouse osteoblastic cell line. The BMP-2 and BMP-4 baculoviruses stimulated strong alkaline phosphatase activity in this cell. The BMP-7 vector induced only weak alkaline phosphatase activity. 35, 36 Recombinant BMP adenoviruses have been the most commonly used vectors in BMP gene therapy. Direct injection of recombinant BMP-2 adenovirus can induce bone formation in immunodefective and immunocompetent mice and athymic nude rats, but could not stimulate ectopic bone formation in Sprague-Dawley rats.
12,30,37,38 Recombinant BMP-4 and BMP-6 adenoviruses can induce ectopic bone growth in athymic nude rats. 28 Franceschi et al 32 mixed ACMVBMP-7 with a bovine bone-derived collagen carrier (10 8 plaque forming units (PFU)/site) and implanted the mixture into mouse muscle and dermal pouches. In both locations, an ossicle containing cortical and trabecular bone and a clearly defined marrow cavity formed at the site of virus implantation within 4 weeks. 32 Recombinant BMP-9 adenoviruses, which include both first-generation and helper-dependent adenoviral vectors, induced the ectopic bone formation in both athymic nude rats and Sprague-Dawley rats. 11, 13, 39 Since different BMP adenoviral vector doses and different animal models were used in previous studies, it remains unclear which BMP vector has the highest potential to stimulate bone formation. In the present study, the osteogenic activities of five different recombinant BMP adenoviruses at identical doses were compared in cell culture, athymic nude rats, and Sprague-Dawley rats.
Results

Viral titers of different recombinant BMP adenoviruses
The viral titers were measured using plaque forming assay and quantitative real-time PCR and expressed as PFU and particles, respectively. The average viral titers were 1 Â 10 10 PFU/ml or 2.76 Â 10 12 particles/ml for ADCMVBMP-2, 4 Â 10 9 PFU/ml or 2.12 Â 10 12 particles/ml for ADCMVBMP-4, 1 Â 10 9 PFU/ml or 7.30 Â 10 11 particles/ml for ADCMVBMP-6, 1 Â 10 9 PFU/ml or 1.47 Â 10 11 particles/ml for ADCMVBMP-7, 1.5 Â 10 9 PFU/ml or 4.38 Â 10 11 particles/ml for ADCMVBMP-9, and 1 Â 10 10 PFU/ml or 2.64 Â 10 11 particles/ml for ADCMVLACZ.
Alkaline phosphatase activity induced by different BMP adenoviruses in C2C12 cells Figure 1 and Table 1a show the relative alkaline phosphatase activities induced by different BMP adenoviruses stained by fast violet B. The lowest viral concentrations that induced the alkaline phosphatasepositive cells were 2 Â 10 4 PFU for ADCMVBMP-2 ( þ ), ADCMVBMP-4 ( þ þ ), and ADCMVBMP-6 ( þ þ ), 2 Â 10 5 PFU for ADCMVBMP-7 ( þ ), and 2 Â 10 3 PFU for ADCMVBMP-9 ( þ ). Table 1b shows the quantitative data of alkaline phosphatase in the infected C2C12 cells. The amount of alkaline phosphatase expressed in C2C12 cells at a viral concentration of 2 Â 10 5 PFU /well from the highest to the lowest was 4890 Â 10 À12 U/well for ADCMVBMP-9, 302 Â 10 À12 U/well for ADCMVBMP-4, 220 Â 10 À12 U/well for ADCMVBMP-6, 45 Â 10 À12 U/ well for ADCMVBMP-2, and 0.43 Â 10 À12 U/well for ADCMVBMP-7. Figure 2 shows the relation between viral concentrations and the alkaline phosphatase activity. This indicates that the expression of alkaline phosphatase induced by different BMP adenoviruses is different and dose dependent.
Quantification of mature BMP expression in the supernatant of C2C12 cells by western blot Figure 3 shows the expressions of the different BMPs in infected C2C12 cells by western blot. Based on densitometry, the amount of secreted BMP in supernatant of C2C12 cells infected with 2 Â 10 6 PFU virus was 620 ng/ ml for ADCMVBMP-2, 129 ng/ml for ADCMVBMP-4, 
Osteogenic potential of different BMP adenoviruses in athymic nude rats
The relative volumes of new bone induced by different BMP adenoviruses on day 30 after viral injections are shown in Figure 4 and 3 for ADCMVBMP-7. The data for each dose were separately analyzed using single-factor ANOVAs, which showed significant differences among BMP groups at both doses (for 10 7 PFU: F¼36.9, Po0.005; for 2 Â 10 6 PFU: F¼80.3, Po0.005). Tukey's W procedure was used for pairwise multiple comparisons of the different BMP groups and the results are shown in Table 2b . 40 The volume of new bone induced by the five BMP adenoviruses was dependent on the BMP viral dose. Figure 5 shows the relation between the viral dose and the volume of new bone in athymic nude rats. The volume of new bone induced by ADCMVBMP-4 and ADCMVBMP-6 was not significantly different (P40.05) at these two doses. The volume of new bone induced with five different BMP adenoviruses at a dose of 10 7 PFU in athymic nude rats in the order ADCMVBMP-64ADCMVBMP-44ADCMVBMP-94ADC-MVBMP-24ADCMVBMP-7. The volume of new bone induced with ADCMVBMP-4, ADCMVBMP-6, or ADCMVBMP-9 was not significantly different from each other at a dose of 2 Â 10 6 PFU, but was significantly larger than the volume induced by ADCMVBMP-2 or ADCMVBMP-7.
The histology of the bone induced by the five different BMP viral vectors in athymic nude rats was subsequently studied after staining with hematoxylin and eosin and with Masson's trichrome ( Figure 6 ). A large number of chondrocytes were observed at 30 days in the ADCMVBMP-2, ADCMVBMP-4, ADCMVBMP-6, and ADCMVBMP-7 treatment groups, but not in the ADCMVBMP-9 group. However, more osteoblasts were seen in the ADCMVBMP-9 group at day 30. Based on the Masson's trichrome staining, ADCMVBMP-9 induced more collagen than the other four BMP vectors. 3) and one sample (lane 4). BMP-2: standard 200 ng, 100 ng, 50 ng, sample 10 ml; BMP-4: Standard 20 ng, 10 ng, 5 ng, sample 10 ml; BMP-6: standard 40 ng, 20 ng, 10 ng, sample 10 ml; BMP-7: standard 100 ng, 50 ng, 25 ng, sample 100 ml; BMP-9: standard 40 ng, 20 ng, 10 ng, sample 50 ml. . Figure 7 shows representative bone volumes on three-dimensional (3-D) reconstructed computerized tomography (CT) scans induced by ADCMVBMP-6 and ADCMVBMP-9 in Sprague-Dawley rats.
Discussion
Numerous studies have shown that the amount of ectopic bone formation induced with protein or cDNA of BMPs is dependent on the member of the BMP family, dose, implant location, presence or absence of bone segmental defect, immune factors, protein or gene carriers, and host species. [41] [42] [43] [44] In this experiment, bone formation potential of five recombinant BMP adenoviruses was compared using three assays. Although the same batches of recombinant BMP adenoviruses were Bone formation induced by different BMP adenoviruses in athymic nude animals is an important indicator of the osteogenic potential of BMP genes. In most cases, athymic nude animals are initially utilized to assess vector activity in vivo, since the host T-cell response may strongly limit the foreign gene's expression. Although adenovirus may initiate a strong immune response in the immunocompetent animals, athymic nude rats do not produce detectable levels of viral neutralizing antibodies (data not shown). Each of the five recombinant BMP viral vectors induced bone formation in athymic nude animals. The volumes of bone induced with recombinant BMP-4 and BMP-6 adenoviruses were not significantly different at the viral dose of 10 7 and 2 Â 10 6 PFU. Most bone volumes were significantly different among groups at 10 7 PFU viral dose, but at 2 Â 10 6 PFU only the volumes of bone induced with ADCMVBMP-2 and ADCMVBMP-7 were significantly smaller than that of other three groups. This result is in agreement with a previous report studying BMP-2, BMP-4, and BMP-7 in the rabbit. The effective dose of BMP-4 to achieve the same effect was 10 times lower than the dose of recombinant human BMP-2 and BMP-7. 50 The ability of ADCMVBMP-4, ADCMVBMP-6, and ADCMVBMP-9 to produce bone in athymic nude rats was different from the ability of these vectors to stimulate alkaline phosphatase activity in C2C12 cells. In athymic nude rats, ADCMVBMP-4 and ADCMVBMP-6 induced most bone formation, whereas ADCMVBMP-9 stimulated most alkaline phosphatase activity in C2C12 cells. The efficacy of the BMP-9 viral vector was higher than that of the BMP-2 viral vector in stimulating alkaline phosphatase activity in C2C12 cells and bone formation in athymic nude rats. This result is in agreement with the function of BMP2 and BMP-9 in human multipotential mesenchymal cells. BMP-9-treated cells showed higher Col2A1 and aggrecan gene expression than BMP-2-treated cells. 51 In this study, the activities of BMP adenoviruses were significantly different between athymic nude and immunocompetent rodents. Since some BMP adenoviruses do not induce bone formation in Sprague-Dawley rats as shown in previous reports and pilot experiments, 10, 28, 30, 37 relatively high doses of ADCMVBMP-2, ADCMVBMP-4, ADCMVBMP-6, and ADCMVBMP-7 were used in Sprague-Dawley rats. However, no bone was seen in rats treated with ADCMVBMP-2, ADCMVBMP-4, and ADCMVBMP-7. The average volume of bone induced with 10 8 PFU of ADCMVBMP-6 was 0.1070.03 cm 3 per injection in the thigh muscle of Sprague-Dawley rats and much smaller than that using 2 Â 10 6 PFU viral solution in athymic nude rats (0.4870.10 cm 3 ). The average volume of bone induced with 10 7 PFU of ADCMVBMP-9 was 0.2970.01 cm 3 in Sprague-Dawley rats and 0.6370.07 cm 3 in athymic nude rats. The immunocompetent animals had significantly less bone formation compared to the athymic nude animals for all BMP adenoviral vectors, although this decrease was BMP vector dependent. In fact, different osteogenic potentials for the same BMP adenoviral vector were seen not only between athymic nude rats and Sprague-Dawley rats, but also among different immunocompetent rat strains, species, and treatment location. We observed different amounts of bone formation among Wistar, Long-Evan, Sprague-Dawley, ACI, PVG, and Fischer344 rats induced with first-generation BMP-9 adenovirus (unpublished data). Although the first-generation BMP-2 adenovirus did not induce ectopic bone formation in immunocompetent rats based on our experiment and previous reports, 10, 28, 30 Baltzer et al 43, 44 had shown that this vector enhanced bone healing in segmental defects in New Zealand white rabbits, and Musgrave et al 37 had shown that this vector induced bone formation in some mice.
The optimal viral dose is a critical step for comparing the osteogenic potential of different BMP viral vectors. Different host species or strains have different optimal doses. The efficiency of the same BMP viral vector in the same host strain is dose dependent (Figures 2 and 5 ). This was confirmed by studying the alkaline phosphatase activity in C2C12 cells and measuring bone volumes in athymic nude rats. The relative activities among different BMP viral vectors may not be significantly different if the doses were very high or low. Multiple viral doses were used in this experiment to determine the relative response to the BMP viral vectors in C2C12 cells and athymic nude rats. For example, the average volume of bone induced with ADCMVBMP-9 in athymic nude rats was not significantly different with ADCMVBMP-4 and ADCMVBMP-6 at a dose of 2 Â 10 6 PFU, but was significantly different at the dose of 10 7 PFU. Other investigators have shown that a higher dose of recombinant BMP-2 adenoviral vector (AxCAOBMP-2) induced larger volumes of bone than a lower dose in immunosuppressed rats. 30 The period of BMP expression may not account for the different vector activities, since all of the BMP vectors were constructed using the first-generation adenovirus, and the immune system had a similar reaction to the different BMP viral vectors. In general, target genes Osteogenic potential of BMP adenoviruses JZ Li et al delivered by adenoviral vectors can be expressed for 2 weeks in immunocompetent animals, and the BMPinduced chemotaxis and mitosis of mesenchymal cells and differentiation of the mesenchymal cells initially into cartilage occur during the first week. It is not clear why the process of bone formation was not initiated with ADBMP-2, ADBMP-4, and ADBMP-7 in SpragueDawley rats, while a similar or lower dose of ADBMP-6 and ADBMP-9 can initiate the process. One possible explanation for their different in vitro and in vivo activity is that different BMPs utilize different receptors and signaling pathways. Most proteins of the BMP family bind to two types of signaling receptors termed as type I and type II receptors. 52 The type II receptors are kinases, which are constitutively active without ligand stimulation. Upon ligand binding and formation of type II and type I receptor complexes, followed by possible receptor conformational changes, type I receptors are phosphorylated and activated by type II receptor kinases. Type I receptor kinases then transmit intracellular signals by phosphorylating Smad proteins. The intracellular substrates, Smads, can be classified into three groups, receptor-regulated Smads (R-Smads: Smad1, Smad5, and Smad8), common-mediator Smads (Co-Smads: Smad4), and inhibitory Smads (I-Smads: Smad6 and Smad7). 53 Specificity of the intracellular signals is determined by R-Smads, with Co-Smads serving as adaptor molecules for R-Smads. In contrast, I-Smads antagonize signaling by R-Smads and Co-Smads. Smad1, Smad5, and Smad8 are known to be activated by BMPs. Type I receptors are termed as activin receptor-like kinases (ALK) 1-7.
54 ALK-3 and ALK-6, which are also called BMP type IA and type IB receptors, respectively, are structurally similar to each other and function as BMP type I receptors by activating R-Smads. In addition, ALK-2 binds certain BMPs, for example, BMP-6 and BMP-7. Interestingly, ALK-3 and ALK-6 activate all three R-Smads (Smad 1, Smad 5, and Smad 8), whereas ALK-2 can activate Smad1 and Smad5, but not Smad8. 48, 55 BMP-2 and BMP-4, the prototypical BMPs, bind to ALK-3/ BMP R-IA and activate R-Smads. BMP-6 and BMP-7 bind ALK-2 and also activate R-Smads. 56 ,57 BMP-9 receptors are different from those of the other BMPs or TGF-bs. 58, 59 These various receptors may account for the differences seen in the osteogenic activity among BMP vectors. Further, although the same kind of receptors were bound by two different BMPs, they may have different functions. 60 Yabe et al 60 found that both BMP-6 and BMP-7 were able to protect neurons against death from induced apoptosis (exposure to serum-free lowpotassium medium) or exposure to glutamate. However, only BMP-6 could stimulate neurite outgrowth, measured with a neurofilament ELISA, an effect that was seen over the first 6 days in culture. This indicates that the different BMPs have different signal transduction pathways. 27, 45, 58, 60, 61 The different BMP receptors and signaling pathways may be the critical factors that account for the different osteogenic activity of BMP viral vectors in Sprague-Dawley rats. Some BMP (eg BMP-2 and BMP-4) signaling pathways may be completely blocked by the immune response stimulated by the adenovirus. Some BMP (eg BMP-6) signaling pathways may be partially interrupted by the immune response, whereas other BMP (eg BMP-9) signaling pathways may not be significantly limited by the host immune response.
In conclusion, among these five BMP adenoviruses, BMP-9 adenovirus displays the most osteogenic potential in vitro and in Sprague-Dawley rats. The potential of BMP-4 and BMP-6 adenoviruses was similar in vitro and in athymic nude rats, and was the highest among the five BMP vectors in athymic nude rats. BMP-6 adenovirus can induce bone formation in Sprague-Dawley rats, but BMP-4 adenovirus does not. The potential of bone formation induced by BMP-2 adenovirus was less than the BMP-4, BMP-6, and BMP-9 viral vectors in all three assays. The BMP-7 adenovirus clearly exhibited the lowest osteogenic activity among the five BMP adenoviruses in all three assays. The osteogenic potential of different BMP adenoviruses is clearly dose and species dependent.
Materials and methods
Recombinant BMP adenoviruses and determination of viral titers
The recombinant hBMP-2, hBMP-4, hBMP-6, and hBMP-9 adenoviruses have been described in our previous reports. 10, 11, 13, 28, 38, 62 The hBMP-7 cDNA was amplified from 293A cells by RT-PCR. The sequences of BMP-7 forward and reverse primers were: BMP-7F 5 0 GCGCGTAGAGCCGGCGCGATGCACGTGCGCTC 3 0 ; and BMP-7R 5 0 CTAGTGGCAGCCACAGGCCCGGAC CACCATGT 3 0 . The BMP-7 PCR fragment was inserted into PCR2.1 TOPO vector (Invitrogen). After the BMP-7 complete encoding cDNA was confirmed with gene sequencing analysis, the BMP-7 fragment was transferred into pcDNA3 then into the pShuttle vector. Linearized pShuttleBMP-7 was cotransfected into BJ5183 Escherichia coli competent cells with pAdEasy1, which contains the E2 and E4 regions of human adenovirus type 5. The first-generation BMP-7 adenovirus was produced and purified according to the previous report. 63 Since our goal was to compare the osteoinductive abilities among BMP adenoviral vectors, an accurate determination of the amount of living virus is a basic requirement for this experiment. The plaque assay was chosen to titer the vectors. To reduce potential errors during the measurement of the viral titers, the titers of the different recombinant BMP adenoviral vectors were performed at the same time using identical 293 cells. These measurements were repeated three times and expressed as PFU. To measure the total viral particles, quantitative real-time PCR was performed using SYBR green reagents and a Roche Lightercycler. The viral DNAs were extracted from purified BMP adenoviruses using a DNA purification kit (Qiagen). The primers were designed from adenoviral E2 regions and were as follows: forward primer 5 0 CTGCATACCAA CATGCC 3 0 ; and reverse primer 5 0 CCGATGTCGCTTTC CA 3 0 . The PCR fragment is 242 bp long from 14 534 to 14 775 in human adenovirus type 5. 64 A serial dilution of purified pAdEasy1 plasmid was used as a reference DNA standard for adenoviral titer determination. The optimizations of Mg 2 þ , primer, and annealing temperature were tested. Each sample was tested in duplicate and copy numbers of viral DNA were calculated using the standard curve. , and 2 Â 10 3 PFU/ml and added into confluent C2C12 cells in 24-well plates. Four plates were used in this experiment. The supernatant was collected 1 week after viral infection in order to measure the BMP concentrations using western blot. The infected C2C12 cells in two plates were stained for alkaline phosphatase activity using a Sigma diagnostic alkaline phosphatase kit. The infected cells in the other two plates were harvested to quantitatively measure the expression of alkaline phosphatase using a SEAP reporter gene assay (Roche). Serial dilutions of standard alkaline phosphatase were used to make the standard curve.
Quantification of mature BMP expression in the supernatant of C2C12 cells by Western blot
The standard recombinant human BMP-2 (CAT 355-BM), BMP-4 (CAT 314-BP-010), BMP-6 (CAT 507-BP-020), and BMP-7 (CAT 354-BP), and mouse anti-human BMP-2 (CAT MAB355), BMP-4 (CAT MAB757), and BMP-7 (CAT MAB354) antibodies were purchased from R&D Systems. The mouse anti-human BMP-6 antibody (CAT MAB1048) was purchased from Chemicon International. The standard human BMP-9 and mouse anti-human BMP-9 antibody were gifts from Genetics Institute. The concentrated supernatant or nonconcentrated supernatant was analyzed in 4-12% SDS-PAGE gel in reducing MES buffer. Three concentrations of standard BMPs were used to make the standard curves. The sample BMP concentrations were calculated based on the film scanning result using a Personal Densitometer SI (Molecular Dynamics).
Osteogenic potential of different BMP adenoviruses in athymic nude rats
The animal protocol was approved by the University of Virginia Animal Research Committee and conformed to National Institutes of Health guidelines. Athymic nude rats (2-month-old) (N¼30) were used in this experiment. The rats were randomly divided into five groups (six rats/group) and each group injected with one of the five BMP adenoviruses. The rats were anesthetized with ketamine HCl and xylazine (Penn Vet). All rats were injected with 50 ml containing 1.0 Â 10 7 PFU of BMP-2,-4,-6,-7, or -9 adenovirus in the left thigh musculature, and 50 ml containing 2.0 Â 10 6 PFU of the same BMP adenovirus in the right thigh musculature. The animals were scanned by CT on a Picker PQ 6000 scanner on day 30 after viral injection. Axial images with a 1 mm collimation and 1 mm table increment were obtained with the standard algorithm with 130 kV, 100 mA, 2 s scan time, and a 40 mm image size. Three-dimensional reconstruction and bone volumes were performed with a Voxel Q workstation. The rats were euthanized after CT scan. Thigh muscles were removed and fixed in 10% neutral buffered formalin. The muscle samples were embedded in paraffin and sectioned. The slides were stained with hematoxylin and eosin and Masson's trichrome.
Osteogenic potential of different BMP adenoviruses in Sprague-Dawley rats
Based on previous reports and our pilot experiments, 10, 28 some recombinant BMP adenoviruses do not induce ectopic bone formation in immunocompetent rats at certain doses. Relatively high concentrations of BMP adenoviruses were therefore used in this experiment for all viral vectors except ADCMVBMP-9. The doses of ADCMVBMP-2, ADCMVBMP-4, ADCMVBMP-6, ADCMVBMP-7, and ADCMVBMP-9 were 1 Â 10 , and 1 Â 10 7 PFU/site, respectively. Sprague-Dawley rats (2-month-old) (N¼30) were used in this experiment. The rats were randomly divided into five groups (six rats/group). The rats were anesthetized with ketamine HCl and xylazine, and injected with the above BMP adenoviruses in the thigh musculature. The CT scan was performed on day 30 after viral injection. The bone volumes were measured with CT scan.
